Search Results - González-Haba E
- Showing 1 - 1 results of 1
-
1
Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain by Galve-Calvo E, González-Haba E, Gostkorzewicz J, Martínez I, Pérez-Mitru A
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book